Search research articles
Contact Us
Filters
Showing results (1-10 of 54) with videos related to
Page
of 6
Sort By:
Expert Opinion on Therapeutic Patents
|
October 5, 2022
An updated patent review of rearranged during transfection (RET) kinase inhibitors (2016-present)
Baku Acharya, Brendan Frett
Future Medicinal Chemistry
|
February 14, 2022
Targeting TGF-β: triumphs and challenges
Baku Acharya, Sayem Miah, Brendan Frett
Expert Opinion on Therapeutic Patents
|
June 12, 2025
An updated patent review of rearranged during transfection (RET) kinase inhibitors (2022-present)
Daniel Armstrong, Maha Hanafi, Brendan Frett
Organic Letters
|
May 24, 2014
Efficient access to 2,3-diarylimidazo[1,2-a]pyridines via a one-pot, ligand-free, palladium-catalyzed three-component reaction under microwave irradiation
Yuanxiang Wang, Brendan Frett, Hong-yu Li
Synlett : Accounts and Rapid Communications in Synthetic Organic Chemistry
|
February 5, 2016
Selective Reduction of Halogenated Nitroarenes with Hydrazine Hydrate in the Presence of Pd/C
Fang Li, Brendan Frett, Hong-Yu Li
Chemmedchem
|
August 14, 2013
Targeting the K-Ras/PDEδ protein-protein interaction: the solution for Ras-driven cancers or just another therapeutic mirage?
Brendan Frett, Yuanxiang Wang, Hong-Yu Li
Organic & Biomolecular Chemistry
|
January 23, 2015
Metal-free, efficient hydrazination of imidazo[1,2-a]pyridine with diethyl azodicarboxylate in neutral media
Yuanxiang Wang, Brendan Frett, Nick McConnell, et al.
Acta Crystallographica. Section E, Structure Reports Online
|
June 25, 2013
(Z)-N-tert-Butyl-2-(4-meth-oxy-anilino)-N'-(4-meth-oxy-phen-yl)-2-phenyl-acetimidamide
Sue A Roberts, Biswajit Saha, Brendan Frett, et al.
Journal of Medicinal Chemistry
|
April 10, 2013
Targeting mutant KRAS for anticancer therapeutics: a review of novel small molecule modulators
Yuanxiang Wang, Christine E Kaiser, Brendan Frett, et al.
RSC Medicinal Chemistry
|
August 4, 2022
FLT3 inhibitors for acute myeloid leukemia: successes, defeats, and emerging paradigms
Baku Acharya, Debasmita Saha, Daniel Armstrong, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 54) with videos related to
Sort By:
Page
of 6
Expert Opinion on Therapeutic Patents
|
October 5, 2022
An updated patent review of rearranged during transfection (RET) kinase inhibitors (2016-present)
Baku Acharya, Brendan Frett
Future Medicinal Chemistry
|
February 14, 2022
Targeting TGF-β: triumphs and challenges
Baku Acharya, Sayem Miah, Brendan Frett
Expert Opinion on Therapeutic Patents
|
June 12, 2025
An updated patent review of rearranged during transfection (RET) kinase inhibitors (2022-present)
Daniel Armstrong, Maha Hanafi, Brendan Frett
Organic Letters
|
May 24, 2014
Efficient access to 2,3-diarylimidazo[1,2-a]pyridines via a one-pot, ligand-free, palladium-catalyzed three-component reaction under microwave irradiation
Yuanxiang Wang, Brendan Frett, Hong-yu Li
Synlett : Accounts and Rapid Communications in Synthetic Organic Chemistry
|
February 5, 2016
Selective Reduction of Halogenated Nitroarenes with Hydrazine Hydrate in the Presence of Pd/C
Fang Li, Brendan Frett, Hong-Yu Li
Chemmedchem
|
August 14, 2013
Targeting the K-Ras/PDEδ protein-protein interaction: the solution for Ras-driven cancers or just another therapeutic mirage?
Brendan Frett, Yuanxiang Wang, Hong-Yu Li
Organic & Biomolecular Chemistry
|
January 23, 2015
Metal-free, efficient hydrazination of imidazo[1,2-a]pyridine with diethyl azodicarboxylate in neutral media
Yuanxiang Wang, Brendan Frett, Nick McConnell, et al.
Acta Crystallographica. Section E, Structure Reports Online
|
June 25, 2013
(Z)-N-tert-Butyl-2-(4-meth-oxy-anilino)-N'-(4-meth-oxy-phen-yl)-2-phenyl-acetimidamide
Sue A Roberts, Biswajit Saha, Brendan Frett, et al.
Journal of Medicinal Chemistry
|
April 10, 2013
Targeting mutant KRAS for anticancer therapeutics: a review of novel small molecule modulators
Yuanxiang Wang, Christine E Kaiser, Brendan Frett, et al.
RSC Medicinal Chemistry
|
August 4, 2022
FLT3 inhibitors for acute myeloid leukemia: successes, defeats, and emerging paradigms
Baku Acharya, Debasmita Saha, Daniel Armstrong, et al.
Page
of 6